DEA Reschedules CBD Medication to Schedule 5

Ganjapreneur
By GrahamSep 27, 2018, 1:50 pm166 pts
The Drug Enforcement Administration announced the rescheduling today of Epidiolex, the first FDA-approved medication derived from the cannabis plant, from Schedule 1 to Schedule 5 under the Controlled Substances Act, CNBC reports. The move paves the way for United Kingdom-based GW Pharmaceuticals, who…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

USDA Database Describes Marijuana As ‘Medicinal’ Even As Federal Government Keeps It In Schedule I 78

Golden Bear Awards: California’s 2025 Best Cannabis Flower, Products Announced 77

Glass House Refinances Preferred Stock 76

Three Ways to Spice Up Your Summer Sesh 74

Last call at the hemp THC beverage bar in St. Louis? 74

Florida marijuana patients can lose access under new state law 74

Discover New York’s top cannabis brands [July 2025] 72

Nebraska: Omaha Tribe Approves Marijuana Legalization on Reservation Lands 71

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.